Logo Image

Podcasts

Recent Episodes

Jonathan Trent, MD, PhD
Greater Flexibility and Improved QOL Represent Key Potential Benefits With Liquid TKI Formulations: With Jonathan Trent, MD, PhD
Sara Nunnery, MD, MSCI; and Sarah Sunshine, MD
An Ophthalmologist Guides Oncologists and Patients Through ADC-Related Eye Toxicities: With Sara Nunnery, MD, MSCI; and Sarah Sunshine, MD
From Trials to the Clinic: Incorporating New Advances in Metastatic TNBC
From Trials to the Clinic: Incorporating New Advances in Metastatic TNBC
Douglas W. Sborov, MD, MS, discussed the FDA approval of isatuximab for subcutaneous injection in multiple myeloma indications.
FDA Approval Insights: Subcutaneous Isatuximab Via an On-Body Delivery System Represents a “Game-Changer” in Multiple Myeloma: With Douglas W. Sborov, MD, MS
Solange Peters, MD, PhD, University Hospital of Lausanne
Positioning PD-L1/VEGF Bispecifics in First-Line Non–Small Cell Lung Cancer: With Solange Peters, MD, PhD
Oncology Unplugged
Precision Oncology, Bispecific Antibodies, and Next-Generation Targeted Therapies Are Reshaping NSCLC Care: With Chandler Park, MD; Stephen V. Liu, MD
Tanios S. Bekaii-Saab, MD
Biomarker-Driven Shifts Signal the Next Generation of mCRC Therapies: With Tanios S. Bekaii-Saab, MD
John N. Allan, MD
Navigating Fixed-Durations Regimens in CLL and Improving Outcomes for High-Risk Patients: With John N. Allan, MD
Marlana M. Orloff, MD, the Alexander & Johnston Family Endowed Clinical Director in Uveal Melanoma, and associate professor at Thomas Jefferson University Hospital
Sequencing Systemic and Liver-Directed Therapy in HLA-A*02:01–Negative Metastatic Uveal Melanoma: With Marlana M. Orloff, MD
Misty D. Shields, MD, PhD; Triparna Sen, MD, PhD, MS; and Ditte Primdahl, MD
Experts Bridge Oncology and Neurology to Catch LEMS Earlier in SCLC: With Misty D. Shields, MD, PhD; Triparna Sen, MD, PhD, MS; and Ditte Primdahl, MD

All series

Oncology Unplugged With Dr Chandler Park

Oncology Unplugged With Dr Chandler Park

Stephen Gottschalk, MD; Giedre Krenciute, PhD

Pediatrics

Breast Cancer Briefing

Breast Cancer Briefing

Marvels in Medicine

Marvels in Medicine

Talking Tumors

Talking Tumors

Biomarker Consortium Commentary

Biomarker Consortium

State of the Science Summits

State of the Science Summits

From Discovery to Delivery: Charting Progress in Gynecologic Oncology

From Discovery to Delivery: Charting Progress in Gynecologic Oncology

OncLive on Air Powered by PER

OncLive on Air Powered by PER

Misty D. Shields, MD, PhD; Triparna Sen, MD, PhD, MS; and Ditte Primdahl, MD

Roundtable Discussions

Samuel A. Kareff, MD, MPH, outgoing chief fellow, hematology and medical oncology, University of Miami Sylvester Comprehensive Cancer Center/Jackson Memorial Hospital

Fellowship

Mariam F. Eskander, MD, MPH

Disparities

Kristen N. Ganjoo, MD, sarcoma specialist, medical oncologist, Stanford Health Care; professor, medicine, Stanford Medicine

Rare Cancers

Kelly E. McCann, MD, PhD, breast medical oncologist, University of California system; Sara Nunnery, MD, MSCI, breast medical oncologist, Tennessee Oncology

Women In Oncology

Noa Biran, MD, breaks down key multiple myeloma data shared at the 2026 ASCO Annual Meeting.

Conference Perspectives

John N. Allan, MD

OncClub

Jonathan Trent, MD, PhD

Oncology Expert Insights

Douglas W. Sborov, MD, MS, discussed the FDA approval of isatuximab for subcutaneous injection in multiple myeloma indications.

FDA Approval Insights

Blood Club

Blood Club

Two Onc Docs

Two Onc Docs

Cancer, Character, and Calling

Cancer, Character, and Calling

How This Is Building Me

How This Is Building Me

All Podcasts

Advanced Non-Small Cell Lung Cancer Meeting in Denver

ByOnclive Team

We went out to Denver, Colorado for a State of the Science Summit on Advanced Non–Small Cell Lung Cancer. The conference spanned screening, molecular profiling, early-stage advances, treatment for oncogenic-driven advanced disease, and immunotherapy.

Breast Cancer Meeting in Houston

ByOnclive Team

We traveled to Houston, Texas for a State of the Science Summit on Breast Cancer on July 11, 2018. The conference covered radiation therapy, triple-negative breast cancer, BRCA-positive tumors, takeaways from the 2018 ASCO Annual Meeting, and more.